SEC Form D private-offering filing

SPRUCE BIOSCIENCES, INC.

Name: SPRUCE BIOSCIENCES, INC. - new SEC Form D private-offering filing, South San Francisco, CA
Published: 2025-10-17

A new SEC Form D private-offering notice from South San Francisco, CA, a $49,999,768 filer-stated offering target in Biotech. The source filing is one click away.

SPRUCE BIOSCIENCES, INC. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing therapies for neurological and endocrine disorders, including an enzyme replacement therapy for MPS IIIB (Sanfilippo Syndrome Type B).

Filed 2025-10-17Filed to raise $49,999,768First money in 2025-10-09Raised so far $49,999,768HQ (as filed) South San Francisco, CASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified sprucebio.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.